Clinical Trials Browser

Phase 2 × Kidney Neoplasms × Muromonab-CD3 × Clear all

NCT00002589 2013-12-18

Lymphocyte Therapy in Treating Patients With Kidney Cancer

Phase 2 Unknown

Carcinoma, Renal Cell, Kidney Neoplasms